Trade & Channel Strategies 2024: Key Challenges of Implementing Direct-to-Patient Models ...
With the implementation of unit-level traceability, the collaboration is expected to provide additional visibility not only within the aseptic manufacturing process, but the entire supply chain ...
Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback